| Quarterly Financials | Dec 2024 | Mar 2025 |
Revenue  | 0 | 118 |
| Expenses | 0 | 109 |
| EBITDA | 0 | 10 |
| Operating Profit % | 0 % | 8 % |
| Depreciation | 0 | 1 |
| Interest | 0 | 3 |
| Profit Before Tax | 0 | 7 |
| Tax | 0 | 2 |
| Net Profit | 0 | 5 |
| EPS in ₹ | 0.00 | 3.04 |
Mahamaya Lifesciences
Mahamaya Lifesciences
179.80
+2.80
(1.58%)
Market Cap
420.85 Cr
PE Ratio
25.07
Volume
8,400.00
Day High - Low
179.80 - 177.05
52W High-Low
205.05 - 111.00
Key Fundamentals
Market Cap
420.85 Cr
EPS
8.33
PE Ratio
25.07
PB Ratio
3.40
Book Value
52.09
EBITDA
33.10
Dividend Yield
0.00 %
Industry
Chemicals Sector
Pesticides & Agrochemicals Return on Equity
26.19
Debt to Equity
1.52
Actual
Company News
View All News
Mahamaya Board meets May 25
May 20, 2026
May 20, 2026Mahamaya Lifesciences Limited will hold a board meeting on May 25, 2026, to consider audited financial results for FY26. Trading window remains closed.
Mahamaya Lifesciences Limited informs BSE about exemption from corporate governance compliance requirements under SEBI regulations due to BSE SME platform listing status.
Mahamaya Lifesciences Limited submitted its quarterly compliance certificate under SEBI regulations for Q4FY26, confirming all shares remain in demat form with no rematerialization requests received.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
611.00 | #1 51,578.74 | 23.83 | #1 51,839.00 | 10.01 | #1 1,914 | 19.93 | 36.70 | |
2,807.70 | 42,597.90 | 32.91 | 6,713.70 | -19.33 | 1,361 | -39.43 | 45.98 | |
456.65 | 22,793.49 | 42.39 | 3,238.32 | -0.93 | 545 | 11.52 | 46.18 | |
4,298.40 | 19,317.91 | 27.96 | 5,593.10 | 7.89 | 568 | 13.12 | 38.43 | |
902.85 | 8,145.56 | #1 11.74 | 5,267.59 | 20.28 | 716 | 56.53 | 42.15 | |
1,062.50 | 4,789.57 | 16.52 | 2,071.30 | 15.49 | 297 | 27.97 | 42.37 | |
226.99 | 4,414.25 | 31.33 | 2,631.40 | 6.54 | 164 | -274.07 | 29.25 | |
164.99 | 3,860.99 | 851.50 | 1,584.46 | #1 27.51 | 10 | 98.20 | 53.61 | |
267.69 | 3,471.11 | 185.25 | 535.94 | 19.15 | 16 | #1 555.56 | 61.63 | |
1,384.40 | 2,301.02 | 16.07 | 1,241.84 | 3.57 | 150 | 52.19 | 43.71 |
Growth Rate
Revenue Growth
23.08 %
Net Income Growth
31.94 %
Cash Flow Change
102.29 %
ROE
23.77 %
ROCE
11.19 %
EBITDA Margin (Avg.)
3.29 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 56 | 78 | 112 | 188 | 310 |
| Fixed Assets | 20 | 21 | 22 | 27 | 43 |
| Current Assets | 33 | 54 | 87 | 157 | 267 |
| Capital Work in Progress | 2 | 2 | 3 | 4 | 6 |
| Investments | 0 | 0 | 0 | 0 | 141 |
| Other Assets | 34 | 54 | 88 | 157 | 0 |
| Total Equity & Liabilities | 56 | 78 | 112 | 188 | 310 |
| Current Liabilities | 30 | 48 | 78 | 132 | 183 |
| Non Current Liabilities | 10 | 11 | 9 | 7 | 5 |
| Total Equity | 16 | 19 | 25 | 49 | 122 |
| Reserve & Surplus | 15 | 18 | 23 | 32 | 99 |
| Share Capital | 1 | 1 | 1 | 18 | 23 |
Cash Flow
| Cash Flow | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 1 | -0 | 1 |
| Investing Activities | -3 | -3 | -2 | -8 |
| Operating Activities | 2 | 1 | -23 | 1 |
| Financing Activities | 1 | 2 | 24 | 9 |
Share Holding
| % Holding | Feb 2025 | Oct 2025 | Nov 2025 | Mar 2026 |
| Promoter | 77.27 % | 77.27 % | 56.35 % | 56.35 % |
| FIIs | 0.00 % | 0.00 % | 6.39 % | 4.77 % |
| DIIs | 0.00 % | 0.00 % | 4.67 % | 2.52 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 0.00 % | 12.72 % | 10.65 % |
| Others | 22.73 % | 22.73 % | 19.88 % | 25.71 % |
| No of Share Holders | 18 | 18 | 1,034 | 584 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 02 Dec 2025 |  Quarterly Result Announcement | NA | 02 Dec 2025 | 116.35 | 115.55 |
| 25 May 2026 | Quarterly Result Announcement | NA | 25 May 2026 | 172.00 | 170.00 |
Announcements
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 26, 2026
May 26, 2026The Audited (Standalone & Consolidated) Financial Results Of The Company For The Half Year And Financial Year Ended 31.03.2026 Along With The Audit Reports ThereonMay 25, 2026
May 25, 2026Board Meeting Outcome for Audited Financial Results (Standalone & Consolidated) For The Half Year And Year Ended On 31.03.2026May 25, 2026
May 25, 2026Board Meeting Intimation for Prior Intimation Of The Board Meeting Pursuant To Regulation 29(1) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015May 20, 2026
May 20, 2026Announcement under Regulation 30 (LODR)-Monitoring Agency ReportMay 15, 2026
May 15, 2026Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 05, 2026
May 05, 2026Intimation Under Regulation 30 (LODR)_Certificate Of AppreciationMay 04, 2026
May 04, 2026Announcement Under Regulation 30(LODR)-Receiving A Certification-"Great Place To Work"Apr 28, 2026
Apr 28, 2026Non-Applicability Of The Compliance On Corporate Governance As Required Under Regulation 27(2) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Apr 15, 2026
Apr 15, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 04, 2026
Apr 04, 2026Disclosure Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulation 2011Apr 03, 2026
Apr 03, 2026Closure of Trading WindowMar 30, 2026
Mar 30, 2026Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 -Utilisation Of Unutilised IPO Proceeds In Subsequent
Fiscal Years.Mar 10, 2026
Mar 10, 2026Announcement Under Regulation 30 (LODR)-Intimation Of Withdrawn Of Participation In Virtual Conference On Monday 9" March 2026.Mar 09, 2026
Mar 09, 2026Intimation Of Participation In Arihant Capital Bharat Connect Virtual Conference Rising Star 2026 On Monday 9Th March 2026.Mar 05, 2026
Mar 05, 2026Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Appointment Of Senior Management Personnel (SMP)Feb 17, 2026
Feb 17, 2026Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Appointment Of Senior Management Personnel (SMP)Feb 17, 2026
Feb 17, 2026Announcement Under Regulation 30 - Receiving A Prestigious Award - Company Of The Year - Medium Scale At ICSCE 2026 DubaiJan 22, 2026
Jan 22, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 16, 2026
Jan 16, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 16, 2026
Jan 16, 2026Submission Of Half Yearly Financial Results - September 2025Dec 02, 2025
Dec 02, 2025Board Meeting Outcome for Submission Of Half Year Results - September 2025Dec 02, 2025
Dec 02, 2025Board Meeting Intimation for Unaudited Standalone And Consolidated Financial ResultsNov 26, 2025
Nov 26, 2025Closure of Trading WindowNov 24, 2025
Nov 24, 2025Listing of Equity Shares of Mahamaya Lifesciences LtdNov 18, 2025
Nov 18, 2025Technical Indicators
RSI(14)
Neutral 56.28
ATR(14)
Less Volatile 8.13
STOCH(9,6)
Neutral 49.77
STOCH RSI(14)
Overbought 90.74
MACD(12,26)
Bullish 0.41
ADX(14)
Strong Trend 30.31
UO(9)
Bearish 59.01
ROC(12)
Uptrend And Accelerating 2.31
WillR(14)
Overbought -5.28
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
